Verubecestat
id:
verubecestat-282-18679883
title:
Verubecestat
text:
Verubecestat (MK-8931) was an experimental drug for the treatment of Alzheimer's disease. It is an inhibitor of beta-secretase 1 (BACE1), which, after initial promise proved disappointing. In April 2012 phase I clinical results were announced. Phase 1b results have also been reported. As of December 2016 it was in two phase 2/3 clinical trials that have progressed to phase 3. EPOCH, was to complete data collection for the primary outcome measure by June 2017. However, in February 2017 Merck halt
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Verubecestat
date created:
date modified:
2023-12-05T18:14:53Z
main entity:
{"identifier":"Q27089141","url":"https://www.wikidata.org/entity/Q27089141"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/96/Verubecestat.svg","width":512,"height":259}
fields total:
13
integrity:
15